+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Smart Pills Market - Growth, Trends, and Forecasts (2020-2025)

  • ID: 4787488
  • Report
  • May 2020
  • Region: Global
  • 111 pages
  • Mordor Intelligence
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • CapsoVision Inc.
  • Medtronics
  • Novartis AG
  • Pentax Medical (Hoya)
  • Phillips
  • Pixie Scientific
  • MORE
The smart pills market is expected to register a CAGR of nearly 14.5%, during the forecast period. A smart drug delivery pill is controlled by electronics and has great flexibility and precise control in delivery location, release rate, and dose. At the same time, it can monitor the local GI environment, report measurements in real-time, and be commanded by an operator to perform an action on demand. This type of performance is impossible with conventional oral drug forms. While there are myriad therapeutic implications, the system can also be viewed from the direction of a smart tool that can be employed to great advantage in drug development of more conventional oral drug products.

A smart pill is a medical device with a small embedded electronic product in it, such as a camera, sensors, or trackers. The increased need for convenient, minimally invasive devices and accurate therapeutic treatment strategies has led to an increased interest in research on smart pills. Products include the Medtronic MiniMed, Insulet Omnipod, and Animas OneTouch Ping. These systems combine elements of a drug reservoir, insulin pump, blood glucose monitor, and handheld management devices.

The delivery of insulin is adapted to the patient’s current blood glucose level and may be delivered on demand by the patient, for example at mealtime is the emerging area of wearable bolus injection devices.

Key Market Trends

Capsule Endoscopy is Expected to Hold Largest Share of Global Smart Pills Market over the Forecast Period
  • Capsule endoscopy is most commonly used to target the small bowel, which is seen as a golden standard if GI bleeding is suspected.
  • Additionally, most hepatologists perform either upper endoscopy or capsule endoscopy for detecting and assessing the severity of esophageal varices.
  • Different capsules enlarge the variety of utilization and diagnostics.
  • Capsule endoscopy has the largest share in the market, as these smart pills are used to treat related disease in the GI tract, which includes Crohn’s disease, obscure GI bleed, celiac disease, and small bowel tumors.
  • Furthermore, increasing prevalence of gastrointestinal disorders is also anticipated to fuel the market over the forecast period.
North America Region Holds the Largest Market Share of Smart Pills Market

North America dominates the Smart Pills market, owing to factors such as technological advancements in the healthcare sector, an increase in the prevalence of colorectal cancer and regulatory approval of new products. All these factors are responsible to provide the growth opportunities for the players operating in this region.

Competitive Landscape

The market competition is set to intensify, as several key players are focusing on the expansion of their smart pills portfolio, through acquisition and collaboration with companies. The smart pills market is expected to open up several opportunities for new players, as well as for currently established market leaders.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • CapsoVision Inc.
  • Medtronics
  • Novartis AG
  • Pentax Medical (Hoya)
  • Phillips
  • Pixie Scientific
  • MORE
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Preference for Minimally-invasive Devices
4.2.2 Rising Burden of Gastrointestinal Disorders
4.2.3 Technological Advancements
4.3 Market Restraints
4.3.1 Increasing Cost with Technological Advancements
4.3.2 Potential Health Risks
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Application Area
5.1.1 Capsule Endoscopy
5.1.1.1 Small Bowel Video Capsule Endoscopy
5.1.1.2 Colon Capsule Endoscopy
5.1.2 Patient Monitoring
5.1.3 Drug Delivery
5.2 By Disease Indication
5.2.1 Occult GI Bleeding
5.2.2 Crohn's Disease
5.2.3 Small Bowel Tumors
5.2.4 Celiac Disease
5.2.5 Inherited Polyposis Syndromes
5.2.6 Neurological Disorders
5.2.7 Other Disease Indications
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 CapsoVision Inc.
6.1.2 Medtronics
6.1.3 Novartis AG
6.1.4 Olympus Medical Technology
6.1.5 Pentax Medical (Hoya)
6.1.6 Phillips
6.1.7 Pixie Scientific
6.1.8 Proteus Digital Health

7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • CapsoVision Inc.
  • Medtronics
  • Novartis AG
  • Olympus Medical Technology
  • Pentax Medical (Hoya)
  • Phillips
  • Pixie Scientific
  • Proteus Digital Health
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll